Average Co-Inventor Count = 9.17
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (12 from 410 patents)
2. Janssen Pharmaceutica Nv (10 from 2,078 patents)
3. Verenium Corporation (4 from 69 patents)
4. Centocor Ortho Biotech Inc. (4 from 31 patents)
5. Other (1 from 832,843 patents)
6. Janssen Sciences Ireland Unlimited Company (1 from 60 patents)
7. Takeda San Diego, Inc. (1 from 53 patents)
8. Basf Enzymes LLC (1 from 39 patents)
9. Bp Corporation North America Inc. (494 patents)
34 patents:
1. 12162951 - Anti-idiotypic antibodies against anti-KLK2 antibodies
2. 12134636 - Immunoglobulins and uses thereof
3. 12030937 - Anti-idiotypic antibodies against anti-GPRC5D antibodies
4. 11780900 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
5. 11767354 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
6. 11746157 - PSMA binding agents and uses thereof
7. 11591379 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
8. 11401315 - Immunoglobulins and uses thereof
9. 10968265 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
10. 10875902 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
11. 10858413 - Immunoglobulins and uses thereof
12. 10787495 - Immunoglobulins and uses thereof
13. 10759854 - Interferon alpha and omega antibody antagonists
14. 10640544 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
15. 10428134 - Immunoglobulins and uses thereof